NewsRx

Search our medical news database

Lifeline Therapeutics

Lifeline Therapeutics elects Dr. Larry Gold to board of directors

Published in Medical Patent Week, November 12th, 2006

Lifeline Therapeutics, Inc., (LFLT), maker of Protandim, a patent-pending dietary supplement designed to increase the body's natural antioxidant defenses, announced the appointment of Larry Gold, PhD, to its board of directors.

Gold has served on the Lifeline Therapeutics scientific advisory board since February 2006 and will now serve in both positions.

Gold is the founder, CEO, chairman of the board, and chief science officer of SomaLogic, Inc., a clinical proteomics company.

"Dr. Larry Gold's industry expertise and entrepreneurial success make him an outstanding addition to the board of directors," said Stephen K. Onody, CEO of...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Medical Patent Week


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook